Purple Biotech (PPBT) Leases (2019 - 2026)
Purple Biotech (PPBT) reported Leases of $161000.0 for Q1 2026, down 27.48% on a QoQ basis from $222000.0 in Q4 2025.
Purple Biotech (PPBT) has 2 years of Leases data on file, last reported at $161000.0 in Q1 2026.
- Quarterly Leases changed N/A year-over-year to $161000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161000.0 (changed N/A YoY) and the FY2025 annual result came in at $222000.0, changed N/A from the prior year.
- Leases eased to $161000.0 in Q1 2026 per PPBT's latest filing, from $222000.0 in the prior quarter.
- Across five years, Leases topped out at $222000.0 in Q4 2025 and bottomed at $161000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 161,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161,000.00 |
| Dec 31, 2025 | 222,000.00 |
| Sep 30, 2025 | 323,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 354,000.00 |
| Jun 30, 2023 | 392,000.00 |
| Mar 31, 2023 | 430,000.00 |
| Dec 31, 2022 | 467,000.00 |
| Sep 30, 2022 | 505,000.00 |
| Jun 30, 2022 | 543,000.00 |
| Mar 31, 2022 | 581,000.00 |
| Dec 31, 2021 | 619,000.00 |
| Sep 30, 2021 | 658,000.00 |
| Jun 30, 2021 | 708,000.00 |
| Mar 31, 2021 | 752,000.00 |
| Dec 31, 2020 | 790,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Dec 31, 2019 | 206,000.00 |
| Jun 30, 2019 | 311,000.00 |